Formosa Laboratories Osake

Formosa Laboratories EBITDA

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Formosa Laboratories (4746.TW) 13.8.2026 päivämäärällä on 803,18 M TWD. Edellisenä vuonna EBITDA (Tulos ennen korkoja, veroja ja poistoja) oli 770,04 M TWD — muutos 4,30 % (korkeampi).

EBITDA

803,18 MTWD

YoY

4,30%

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Formosa Laboratories on 2026 803,18 M TWD. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Formosa Laboratories oli 2025 770,04 M TWD. Se laskee 4,30% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Formosa Laboratories Osakeanalyysi

Mitä Formosa Laboratories tekee? Formosa Laboratories, Inc. is a renowned company in the field of research and development, pharmaceuticals, and diagnostics, operating in the industry for over 30 years. Founded in 1989, the company has become one of the leading providers of innovative solutions and products that allow its customers to improve their healthcare and enhance their quality of life. The business model of Formosa Laboratories is focused on meeting the high demands of its customers. The company works closely with medical professionals, scientists, and researchers to develop products that meet the needs of patients. With an experienced and diverse team of experts in areas such as research and development, quality control, production, marketing, and sales, Formosa Laboratories is able to offer fast and effective solutions for all customer requirements. The company has divided its various business areas into different divisions, each specialized in different areas of medicine and diagnostics. The three main business divisions are research and development, pharmaceuticals, and diagnostics. In the field of research and development, the company offers services such as preclinical research, biologics research, and development strategies. The company is dedicated to researching new control procedures and technologies to ensure the effectiveness of its solutions. Formosa Laboratories takes pride in its innovative research and development team, which stays up to date with the latest technology and continuously develops new products to meet the needs of its customers. In the pharmaceutical field, the company offers a wide range of prescription and non-prescription medications prescribed by doctors around the world. Formosa Laboratories relies on close collaboration with its customers to ensure that each patient receives the best possible medical care. The company is committed to manufacturing high-quality and safe medications. In the field of diagnostics, the company offers a variety of diagnostic tests and kits that allow for accurate and fast diagnosis of various diseases and conditions. With advanced technology and precise test results, Formosa Laboratories helps doctors and medical professionals make quick and accurate diagnoses to start treatment as soon as possible. Over the years, Formosa Laboratories has developed numerous products that have improved people's lives and fought against diseases. Some of the company's well-known products include: - Influenza Rapid Tests: A fast and accurate test for diagnosing the flu. - Pregnancy Test Kits: A traditional pregnancy test that is able to confirm or exclude pregnancy in a woman. - Needle-free Syringes: An innovation that allows for medication injection without a needle. In conclusion, Formosa Laboratories Inc is a significant company in the medical and diagnostics industry, dedicated to manufacturing high-quality and safe products. With its experienced and qualified team, the company is able to offer fast and effective solutions tailored to the individual needs of its customers. Formosa Laboratories on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Formosa Laboratories osakkeesta

Yhtiön Formosa Laboratories EBITDA (Tulos ennen korkoja, veroja ja poistoja) on 803,18 M TWD vuonna 2026.

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Formosa Laboratories muuttui arvosta 770,04 M TWD arvoon 803,18 M TWD, mikä edustaa 4,30 % muutosta. Arvo on korkeampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBITDA (Tulos ennen korkoja, veroja ja poistoja) Formosa Laboratories:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBITDA mittaa operatiivista suorituskykyä ennen rahoitusrakenteen, veroympäristön ja muiden kuin käteispoisto-osuuksien vaikutusta.

EBITDA = EBIT + Poistot

EBITDA (Tulos ennen korkoja, veroja ja poistoja):n TWD on sijoittajille tärkeä tekijä. Muutokset tässä tunnusluvussa voivat signaloida parantuvia tai heikentyneitä perustekijöitä, mikä vaikuttaa suoraan osakekurssiin. Eulerpoolissa voit seurata EBITDA (Tulos ennen korkoja, veroja ja poistoja):n Formosa Laboratories historiallisesti ja reaaliajassa.

Access this data via the Eulerpool API

Tuloslaskelma — Formosa Laboratories

Kaikki tunnusluvut — Formosa Laboratories